Already a print subscriber?
Already a digital subscriber?
Never Miss a Story
Activate Print Subscription
Manage My Account
Celebs & Gossip
Things to Do
Home & Design
Sex & Dating
Find a Home
Print Offers Online
Daily News logo
PhillyPharma Archive: March, 2013
Follow Philly.com PhillyPharma :
Health & Pharma
AstraZeneca cutting 1200 jobs in Wilmington, moving R&D to Gaithersburg, Md.
Mon, Mar 18, 2013, 11:04 AM
British-based drugmaker AstraZeneca said Monday morning it would cut 1200 job from its facility in Wilmington and move research and development...
N.J. compounding pharmacy recalls all products because of fear of mold contamination
Mon, Mar 18, 2013, 7:25 AM
New Jersey-based compounding pharmacy Med Prep Consulting Inc., announced that a "nationwide recall of all lots of all compounded products...
GlaxoSmithKline's Andrew Witty says $1 billion price tag for drug development is a "myth"
Fri, Mar 15, 2013, 12:13 PM
GlaxoSmithKline chief executive officer Andrew Witty said Thursday the pharmaceutical industry's common estimate of $1 billion in average cost...
Pennsylvania Bio's 2013 awards
Fri, Mar 15, 2013, 7:03 AM
Pennsylvania Bio, a state-based trade organization representing the life sciences industry, gave out awards at its annual dinner the other...
FDA proposes looser rules for evaluating new drugs to fight Alzheimer's disease
Thu, Mar 14, 2013, 7:06 AM
In the continuing search for the fountain of youth, the U.S. Food and Drug Administration is proposing to loosen the rules for approving drugs...
Merck's Ken Frazier discounts Paterno family report on Penn State-Sandusky scandal, according to AP
Thu, Mar 14, 2013, 7:00 PM
Philadelphia native and Merck chief executive officer Ken Frazier, who serves on the Penn State board of trustees, said Thursday that the report...
Former J&J CEO and chairman Bill Weldon gets $29.8 million for 2012
Wed, Mar 13, 2013, 2:42 PM
Former Johnson & Johnson chief Bill Weldon will get $29.8 million for 2012, according to documents filed by the company with the Securities...
Glaxo's R&D shuffle means the end of red wine unit (Sirtris Pharmaceuticals)
Wed, Mar 13, 2013, 8:35 AM
GlaxoSmithKline's announcement of reshuffling of its research and development people and facilities impacted employees at facilities in Philadelphia...
David Sell is a sports web producer. In previous lives, he has been a reporter and editor in the Sports, Metro and Business sections.